Buchwald P - Search Results

1

Pharmacokinetic and pharmacodynamic evaluations of the zwitterionic metabolite of a new series of N-substituted soft anticholinergics.

Wu WM, Buchwald P, Mori N, Ji F, Wu J, Bodor N. Wu WM, et al. Among authors: buchwald p. Pharm Res. 2005 Dec;22(12):2035-44. doi: 10.1007/s11095-005-8174-z. Epub 2005 Sep 26. Pharm Res. 2005. PMID: 16170596

2

Receptor binding studies of soft anticholinergic agents.

Huang F, Buchwald P, Browne CE, Farag HH, Wu WM, Ji F, Hochhaus G, Bodor N. Huang F, et al. Among authors: buchwald p. AAPS PharmSci. 2001;3(4):E30. doi: 10.1208/ps030430. AAPS PharmSci. 2001. PMID: 12049493 Free PMC article.

3

Synthesis and pharmacological effects of new, N-substituted soft anticholinergics based on glycopyrrolate.

Ji F, Wu W, Dai X, Mori N, Wu J, Buchwald P, Bodor N. Ji F, et al. Among authors: buchwald p. J Pharm Pharmacol. 2005 Nov;57(11):1427-35. doi: 10.1211/jpp.57.11.0008. J Pharm Pharmacol. 2005. PMID: 16259775

4

Pharmacological effects of some newly developed soft anticholinergics and a receptor-binding QSAR study.

Mori N, Buchwald P, Wu WM, Ji F, Hochhaus G, Bodor N. Mori N, et al. Among authors: buchwald p. Pharmazie. 2006 Feb;61(2):148-53. Pharmazie. 2006. PMID: 16526564

5

Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate--syntheses and pharmacological evaluations.

Wu WM, Wu J, Mori N, Buchwald P, Bodor N. Wu WM, et al. Among authors: buchwald p. Pharmazie. 2008 Mar;63(3):200-9. Pharmazie. 2008. PMID: 18444508

6

In vitro and in vivo evaluations of dihydroquinoline- and dihydroisoquinoline-based targetor moieties for brain-specific chemical delivery systems.

Bodor N, Farag HH, Barros MD, Wu WM, Buchwald P. Bodor N, et al. Among authors: buchwald p. J Drug Target. 2002 Feb;10(1):63-71. doi: 10.1080/10611860290007540. J Drug Target. 2002. PMID: 11996088

7

Designing safer (soft) drugs by avoiding the formation of toxic and oxidative metabolites.

Bodor N, Buchwald P. Bodor N, et al. Among authors: buchwald p. Methods Mol Biol. 2002;186:301-12. doi: 10.1385/1-59259-173-6:301. Methods Mol Biol. 2002. PMID: 12013781 No abstract available.

8

Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems.

Bodor N, Buchwald P. Bodor N, et al. Among authors: buchwald p. AAPS J. 2005 Dec 7;7(4):E820-33. doi: 10.1208/aapsj070479. AAPS J. 2005. PMID: 16594634 Free PMC article. Review.

9

Corticosteroid design for the treatment of asthma: structural insights and the therapeutic potential of soft corticosteroids.

Bodor N, Buchwald P. Bodor N, et al. Among authors: buchwald p. Curr Pharm Des. 2006;12(25):3241-60. doi: 10.2174/138161206778194132. Curr Pharm Des. 2006. PMID: 17020532 Review.

10

Pharmacokinetics of the sequential metabolites of loteprednol etabonate in rats.

Wu WM, Huang F, Lee Y, Buchwald P, Bodor N. Wu WM, et al. Among authors: buchwald p. J Pharm Pharmacol. 2008 Mar;60(3):291-7. doi: 10.1211/jpp.60.3.0003. J Pharm Pharmacol. 2008. PMID: 18284808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters